To improve your experience on Lilly TrialGuide, please use the latest version of Chrome, Firefox, Safari, or Internet Explorer, with JavaScript enabled.
This website is not optimized for your browser, as configured.

Listen to the Youth Voice for Patient-Centric Pediatric Drug Development

ListenToTheYouthVoiceForPatientCentricPediatricDrugDevelopment FeatureImage 21Sept2020-01

Editor's Note: Courtney Tate is a Senior Clinical Research Scientist in the Pediatric Capabilities Function supporting pediatric research at Eli Lilly and Company. Courtney obtained her bachelor’s degrees in chemistry and molecular biology from the University of Indianapolis and doctoral degree in biochemistry and molecular biology from Indiana University School of Medicine.

CMT picture

One of the best ways to become more patient-centric is to hear directly from the people who may eventually use our medicines. This includes getting input from youth for pediatric research. What is important to them? What would make their life better? How could we improve the medicines, materials, devices, trial designs, and apps that they will be using or taking part in?

In the past few years, key stakeholders in drug development and research (advocacy groups, patients/caregivers, clinicians, industry, and regulatory agencies) have been advocating for pharmaceutical companies to become more patient-centric, so much so that the FDA has a Patient-Focused Drug Development effort that includes developing a series of four patient-focused drug development guidance documents. These documents address how stakeholders can collect and submit patient experience data and other relevant patient information for medical product development and regulatory decision making.

iCAN works to bring patient-centricity to pediatric drug development

International Children’s Advisory Network, Inc. (iCAN), is a worldwide consortium of children’s advisory groups, known as Kids Impacting Disease Through Science (KIDS) and Young Persons Advisory Groups (YPAGS). These dedicated youth member groups work in unison around the world to provide a voice for children and families in medicine, research, and innovation. iCAN members express their desire to be part of something bigger than themselves and to make a difference through meaningful contributions in the lives of children and youth living with a medical condition. iCAN members voice their true opinions, needs, ideas and experiences which enables their voices to matter, be understood, and be valued.

Over the past few years, Lilly and iCAN have collaborated in person at the iCAN Annual Summit and virtually on numerous projects to gain insightful input from youth to ensure we are creating patient-facing materials that are age-appropriate, comprehensible, and useful to the child and caregiver/parent. For example, we’ve obtained feedback and perspectives from iCAN youth on educational and trial materials: a training brochure for pill swallowing, a placebo response video, Understanding Clinical Trials Comic Books, and our assent templates or documents for youth to give permission to participate in research. In addition, we’ve gotten iCAN youth input on device preferences, level of comfort, and their innovative ideas around continuous data collection in clinical trials, as well as vital information to guide our age-appropriate formulation strategies.

We also want to make sure we design trials that are feasible and are really measuring what is important to the youth and their family. They are the experts on what it is like to live with their condition, so when you listen to their perspective, you get a small glimpse into their life. Research for children is complicated for many reasons, which is all the more reason to ensure we get youth input when possible. I remember one young man with Duchenne Muscular Dystrophy who shared that he didn’t care about the standard 6-minute walk test, which measures how far he could walk in 6 minutes. Rather, he cared about being able to put his shirt on, hold his own glass and toast with his friends, and get from his desk to his bed.

The iCAN youth are a true inspiration. Their stories are both heart-wrenching and motivational and stick with me long after I hear them. These youth are dedicated, driven, extremely bright, and never cease to amaze me with their creativity and unique concepts. I can’t say enough about the invaluable partnership with iCAN. The youth voices are critical to pediatric drug development and research.

I hate to admit it has been over 20 years since I was a child. Of course, I’ve gained experience along the way to approaching middle age, but I’ve also lost the way I used to think and feel as a child. The world in which our children are growing up is so different from the world I grew up in, or that my parents and grandparents grew up in. In order to stay current and tailor the way we approach pediatric drug development, we have to listen and respond to what the youth and parents/caregivers are telling us. Just like raising children takes a village, it takes all of us working together - the patients/parents/caregivers/families, industry, clinicians, advocacy groups, and regulators - to be successful in achieving Lilly’s purpose of uniting caring with discovery to create medicines that make life better for people around the world.

Tags: Patient Stories,

Recent Articles

TheCOVID-19PandemicChangedHowSitesConductClinicalTrialsForever FeatureImage 22July2021-01

The COVID-19 Pandemic Changed How Sites Conduct Clinical Trials Forever

Kevin Hudziak Photo
Kevin Hudziak
July 29th, 20213 minute read

To better understand how various countries adapted to execute clinical trials during a pandemic, we conducted a series of virtual feedback sessions with clinicians from all over the world.

ThePathFromHCPtoResearcher FeatureImage 24Feb2021-01

The Path from HCP to Researcher: A Word of Advice

LTGBlogAuthors LillyGuestAuthorIcon 20July2018
Lilly Guest Author
April 21st, 20215 minute read

If you’re a physician interested in getting involved in clinical research, you must understand that it can be a big career shift. Luckily, Kamnesh Pradhan has valuable advice to share.

WeMustIncreaseDiversityInClinicalTrials FeatureImage 24Feb2021-01

Paving the Way to Better Diversity in Clinical Trials

LTGBlogAuthors LillyGuestAuthorIcon 20July2018
Lilly Guest Author
February 26th, 20218 minute read

To discuss what Lilly is doing to increase diversity in clinical trials, we spoke with two outstanding women who are leading the charge.

ResourcesToHelpAspiringClinicalResearchers FeatureImage 3Feb2021-01

Resources to Help Aspiring Clinical Researchers

Leigh Anne Naas Headshot
Leigh Anne Naas
February 10th, 20214 minute read

If you’re thinking about becoming a clinical researcher, it might be hard to know where to begin. We’ve outlined several resources to help you understand what to expect in a clinical research role.

StudyCoordinatorPatientPartnerThroughClinicalTrials FeatureImage 15Dec2020

Study Coordinator: Patient Partner Through Clinical Trials

LTGBlogAuthors GuestAuthorIcon 20July2018
Guest Author
January 13th, 20217 minute read

Study coordinators are a key part of the clinical trial journey. To learn more about what they do, read our interview with study coordinator, Kelly Roberts.